Hayden is an assistant editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2021, where she produces written and video content covering multiple disease states.
She has a BA in journalism & media studies from Rutgers University. You can connect with Hayden on LinkedIn.
AMCP's Adam Colborn Explains Obstacles, Solutions for Interchangeability in the Biosimilars Market
July 3rd 2023Adam Colborn, JD, director of government relations at the Academy of Managed Care Pharmacy (AMCP), also explains what health systems can do to improve patient access to biosimilars.
Read More
Dr Scott Soefje Says New Biosimilar Workflow "Completely Simplified the System"
June 28th 2023Scott Soefje, PharmD, director of pharmacy cancer care at Mayo Clinic, explains how education can help with biosimilar adoption and how an updated biosimilar workflow has simplified the prior authorization process.
Read More
FDA Approves Jardiance, Synjardy for Pediatric T2D
June 21st 2023Yesterday’s FDA approvals of a new indication for empagliflozin and combination empagliflozin with metformin hydrochloride for pediatric type 2 diabetes (T2D) provide a new class of oral drugs to treat the condition in children.
Read More
Dr David Maahs Highlights Unmet Needs in Youth T1D Care
June 20th 2023Improving access to diabetes technology so that everyone can benefit is a top priority, said David Maahs, MD, PhD, professor of pediatrics at Stanford University and division chief of pediatric endocrinology at Lucile Packard Children’s Hospital.
Read More
Low PrEP Uptake, Persistence in Mississippi Same-Day Prescription Program
June 16th 2023An evaluation of a same-day HIV pre-exposure prophylaxis (PrEP) program in Jackson, Mississippi, showed that most individuals given a same-day prescription either never started PrEP or stopped use within 3 months.
Read More
Applying 4T Study Findings to the Managed Care Space: Dr David Maahs
June 16th 2023David Maahs, MD, PhD, professor of pediatrics at Stanford University and division chief of pediatric endocrinology at Lucile Packard Children’s Hospital, talks about the Timely Interventions for Diabetes Excellence dashboard, increases in continuous glucose monitoring, and more.
Read More
Dr Samyukta Mullangi: To Affect Prescribing Behavior, Payer Incentive Alignment Is Critical
June 9th 2023If payers can agree on consensus criteria to improve care quality or costs, that will help physicians remember and try to be compliant, said Samyukta Mullangi, MD, MBA, incoming medical director at Thyme Care.
Read More
Early CGM Initiation, Remote Data Review Decreased HbA1C in Youth With T1D: Dr David Maahs
June 8th 2023The pilot 4T study showed consistent hemoglobin A1C improvement in all children with type 1 diabetes (T1D) after 1 year, underscoring the importance of early continuous glucose monitoring (CGM) following diagnosis, explained David Maahs, MD, PhD, professor of pediatrics at Stanford University and division chief of pediatric endocrinology at Lucile Packard Children’s Hospital.
Read More
Dr Samyukta Mullangi on the EOM: MIPS Disproportionately Penalizes Oncologists; ePROs Need Refining
June 3rd 2023"It's really important that oncologists are on level footing along with the rest of their medical peers," said Samyukta Mullangi, MD, MBA, incoming medical director at Thyme Care.
Read More
US Government Spent Far More on Costly HIV PrEP Development Than Previously Thought
June 2nd 2023According to new estimates, the US government spent between $143 million and $314 million in 2022 inflation-adjusted dollars funding the development of tenofovir disoproxil fumarate-emtricitabine. The previous estimate was around $50 million.
Read More
Dr Amal Agarwal: Value-Based Contracts Can Help Align Incentives in Dialysis
June 2nd 2023Amal Agarwal, DO, MBA, chief clinical officer at Monogram Health, explains the importance of value-based agreements in dialysis care, and the issue of dialysis prevalence among low-income and marginalized communities.
Read More